General Counsel of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR), O’Brien Patrick, sells 25,000 shares worth $1,810,346
According to Arrowhead Pharmaceuticals, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jan 07 06:11 PM, company General Counsel, O'Brien Patrick disclosed selling 25,000 shares at a cost of $72.41. At the time of this transaction (Jan 06), this trade was worth $1,810,346 in total. As of Jan 06, O'Brien Patrick now owns 293,375 shares in total worth about $23,314,511.25.
For the last few recent trades made by Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) General Counsel, O'Brien Patrick, we have the following information:
- SEC Form 4 filing: Jan 06: Sold 14,625 shares at the rate of $60.12 per share. Total worth of this trade was $879,261. Total number of shares owned as of Jan 06 were 258,375
- SEC Form 4 filing: May 28: Sold 30,000 shares at the rate of $24.88 per share. Total worth of this trade was $746,400. Total number of shares owned as of May 28 were 203,000
- SEC Form 4 filing: Jan 18: Sold 72,000 shares at the rate of $14.43 per share. Total worth of this trade was $1,038,960. Total number of shares owned as of Jan 18 were 233,000
Posted by
George Daniels
on Thursday January 07 2021, 10:06 PM EST.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
